Global Immunotherapy Drugs Market Size, Status and Forecast 2018-2025

Published: Aug, 2018 | Pages: 90 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)

This report focuses on the global Immunotherapy Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immunotherapy Drugs development in United States, Europe and China.

Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.
North America is expected to account for largest share in the immunotherapy drugs market, by region in 2018. Asia-Pacific is expected to be the fastest-growing regional segment in the market. The high growth of this segment can primarily be attributed to the low cost of manufacturing and acceptable regulatory scenario in this region.
In 2017, the global Immunotherapy Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Roche
Merck
Novartis
Johnson & Johnson
Glaxosmithkline
Amgen
Abbvie
Astrazeneca
Bristol-Myers Squibb
ELI Lilly

Market segment by Type, the product can be split into
Monoclonal Antibodies
Adult Vaccines
Checkpoint Inhibitors
Interferons Alpha & Beta
Interleukins
Others

Market segment by Application, split into
Cancer
Autoimmune & Inflammatory Diseases
Infectious Diseases
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Immunotherapy Drugs status, future forecast, growth opportunity, key market and key players.
To present the Immunotherapy Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Immunotherapy Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

 Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Immunotherapy Drugs Market Size Growth Rate by Type (2013-2025)
        1.4.2 Monoclonal Antibodies
        1.4.3 Adult Vaccines
        1.4.4 Checkpoint Inhibitors
        1.4.5 Interferons Alpha & Beta
        1.4.6 Interleukins
        1.4.7 Others
    1.5 Market by Application
        1.5.1 Global Immunotherapy Drugs Market Share by Application (2013-2025)
        1.5.2 Cancer
        1.5.3 Autoimmune & Inflammatory Diseases
        1.5.4 Infectious Diseases
        1.5.5 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Immunotherapy Drugs Market Size
    2.2 Immunotherapy Drugs Growth Trends by Regions
        2.2.1 Immunotherapy Drugs Market Size by Regions (2013-2025)
        2.2.2 Immunotherapy Drugs Market Share by Regions (2013-2018)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Immunotherapy Drugs Market Size by Manufacturers
        3.1.1 Global Immunotherapy Drugs Revenue by Manufacturers (2013-2018)
        3.1.2 Global Immunotherapy Drugs Revenue Market Share by Manufacturers (2013-2018)
        3.1.3 Global Immunotherapy Drugs Market Concentration Ratio (CR5 and HHI)
    3.2 Immunotherapy Drugs Key Players Head office and Area Served
    3.3 Key Players Immunotherapy Drugs Product/Solution/Service
    3.4 Date of Enter into Immunotherapy Drugs Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Immunotherapy Drugs Market Size by Type (2013-2018)
    4.2 Global Immunotherapy Drugs Market Size by Application (2013-2018)

5 United States
    5.1 United States Immunotherapy Drugs Market Size (2013-2018)
    5.2 Immunotherapy Drugs Key Players in United States
    5.3 United States Immunotherapy Drugs Market Size by Type
    5.4 United States Immunotherapy Drugs Market Size by Application

6 Europe
    6.1 Europe Immunotherapy Drugs Market Size (2013-2018)
    6.2 Immunotherapy Drugs Key Players in Europe
    6.3 Europe Immunotherapy Drugs Market Size by Type
    6.4 Europe Immunotherapy Drugs Market Size by Application

7 China
    7.1 China Immunotherapy Drugs Market Size (2013-2018)
    7.2 Immunotherapy Drugs Key Players in China
    7.3 China Immunotherapy Drugs Market Size by Type
    7.4 China Immunotherapy Drugs Market Size by Application

8 Japan
    8.1 Japan Immunotherapy Drugs Market Size (2013-2018)
    8.2 Immunotherapy Drugs Key Players in Japan
    8.3 Japan Immunotherapy Drugs Market Size by Type
    8.4 Japan Immunotherapy Drugs Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Immunotherapy Drugs Market Size (2013-2018)
    9.2 Immunotherapy Drugs Key Players in Southeast Asia
    9.3 Southeast Asia Immunotherapy Drugs Market Size by Type
    9.4 Southeast Asia Immunotherapy Drugs Market Size by Application

10 India
    10.1 India Immunotherapy Drugs Market Size (2013-2018)
    10.2 Immunotherapy Drugs Key Players in India
    10.3 India Immunotherapy Drugs Market Size by Type
    10.4 India Immunotherapy Drugs Market Size by Application

11 Central & South America
    11.1 Central & South America Immunotherapy Drugs Market Size (2013-2018)
    11.2 Immunotherapy Drugs Key Players in Central & South America
    11.3 Central & South America Immunotherapy Drugs Market Size by Type
    11.4 Central & South America Immunotherapy Drugs Market Size by Application

12 International Players Profiles
    12.1 Roche
        12.1.1 Roche Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Immunotherapy Drugs Introduction
        12.1.4 Roche Revenue in Immunotherapy Drugs Business (2013-2018)
        12.1.5 Roche Recent Development
    12.2 Merck
        12.2.1 Merck Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Immunotherapy Drugs Introduction
        12.2.4 Merck Revenue in Immunotherapy Drugs Business (2013-2018)
        12.2.5 Merck Recent Development
    12.3 Novartis
        12.3.1 Novartis Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Immunotherapy Drugs Introduction
        12.3.4 Novartis Revenue in Immunotherapy Drugs Business (2013-2018)
        12.3.5 Novartis Recent Development
    12.4 Johnson & Johnson
        12.4.1 Johnson & Johnson Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Immunotherapy Drugs Introduction
        12.4.4 Johnson & Johnson Revenue in Immunotherapy Drugs Business (2013-2018)
        12.4.5 Johnson & Johnson Recent Development
    12.5 Glaxosmithkline
        12.5.1 Glaxosmithkline Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Immunotherapy Drugs Introduction
        12.5.4 Glaxosmithkline Revenue in Immunotherapy Drugs Business (2013-2018)
        12.5.5 Glaxosmithkline Recent Development
    12.6 Amgen
        12.6.1 Amgen Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Immunotherapy Drugs Introduction
        12.6.4 Amgen Revenue in Immunotherapy Drugs Business (2013-2018)
        12.6.5 Amgen Recent Development
    12.7 Abbvie
        12.7.1 Abbvie Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Immunotherapy Drugs Introduction
        12.7.4 Abbvie Revenue in Immunotherapy Drugs Business (2013-2018)
        12.7.5 Abbvie Recent Development
    12.8 Astrazeneca
        12.8.1 Astrazeneca Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Immunotherapy Drugs Introduction
        12.8.4 Astrazeneca Revenue in Immunotherapy Drugs Business (2013-2018)
        12.8.5 Astrazeneca Recent Development
    12.9 Bristol-Myers Squibb
        12.9.1 Bristol-Myers Squibb Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Immunotherapy Drugs Introduction
        12.9.4 Bristol-Myers Squibb Revenue in Immunotherapy Drugs Business (2013-2018)
        12.9.5 Bristol-Myers Squibb Recent Development
    12.10 ELI Lilly
        12.10.1 ELI Lilly Company Details
        12.10.2 Company Description and Business Overview
        12.10.3 Immunotherapy Drugs Introduction
        12.10.4 ELI Lilly Revenue in Immunotherapy Drugs Business (2013-2018)
        12.10.5 ELI Lilly Recent Development

13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details

List of Tables and Figures

    Table Immunotherapy Drugs Key Market Segments
    Table Key Players Immunotherapy Drugs Covered
    Table Global Immunotherapy Drugs Market Size Growth Rate by Type 2013-2025 (Million US$)
    Figure Global Immunotherapy Drugs Market Size Market Share by Type 2013-2025
    Figure Monoclonal Antibodies Figures
    Table Key Players of Monoclonal Antibodies
    Figure Adult Vaccines Figures
    Table Key Players of Adult Vaccines
    Figure Checkpoint Inhibitors Figures
    Table Key Players of Checkpoint Inhibitors
    Figure Interferons Alpha & Beta Figures
    Table Key Players of Interferons Alpha & Beta
    Figure Interleukins Figures
    Table Key Players of Interleukins
    Figure Others Figures
    Table Key Players of Others
    Table Global Immunotherapy Drugs Market Size Growth by Application 2013-2025 (Million US$)
    Figure Cancer Case Studies
    Figure Autoimmune & Inflammatory Diseases Case Studies
    Figure Infectious Diseases Case Studies
    Figure Others Case Studies
    Figure Immunotherapy Drugs Report Years Considered
    Table Global Immunotherapy Drugs Market Size 2013-2025 (Million US$)
    Figure Global Immunotherapy Drugs Market Size and Growth Rate 2013-2025 (Million US$)
    Table Global Immunotherapy Drugs Market Size by Regions 2013-2025 (Million US$)
    Table Global Immunotherapy Drugs Market Size by Regions 2013-2018 (Million US$)
    Table Global Immunotherapy Drugs Market Share by Regions 2013-2018
    Figure Global Immunotherapy Drugs Market Share by Regions 2013-2018
    Figure Global Immunotherapy Drugs Market Share by Regions 2018
    Table Market Top Trends
    Table Global Immunotherapy Drugs Revenue by Manufacturers (2013-2018) (Million US$)
    Table Global Immunotherapy Drugs Market Share by Manufacturers (2013-2018)
    Figure Global Immunotherapy Drugs Market Share by Manufacturers in 2018
    Table Global Immunotherapy Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Immunotherapy Drugs Product/Solution/Service
    Table Date of Enter into Immunotherapy Drugs Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Immunotherapy Drugs Market Size by Type (2013-2018) (Million US$)
    Table Global Immunotherapy Drugs Market Size Share by Type (2013-2018)
    Figure Global Immunotherapy Drugs Market Size Market Share by Type (2013-2018)
    Table Global Immunotherapy Drugs Market Size by Application (2013-2018) (Million US$)
    Table Global Immunotherapy Drugs Market Size Share by Application (2013-2018)
    Figure Global Immunotherapy Drugs Market Size Market Share by Application (2013-2018)
    Figure Global Immunotherapy Drugs Revenue Market Share by Application in 2017
    Figure United States Immunotherapy Drugs Market Size 2013-2018 (Million US$)
    Table United States Key Players Immunotherapy Drugs Revenue (2017-2018) (Million US$)
    Table United States Key Players Immunotherapy Drugs Market Share (2017-2018)
    Table United States Immunotherapy Drugs Market Size by Type (2013-2018) (Million US$)
    Table United States Immunotherapy Drugs Market Share by Type (2013-2018)
    Table United States Immunotherapy Drugs Market Size by Application (2013-2018) (Million US$)
    Table United States Immunotherapy Drugs Market Share by Application (2013-2018)
    Figure Europe Immunotherapy Drugs Market Size 2013-2018 (Million US$)
    Table Europe Key Players Immunotherapy Drugs Revenue (2017-2018) (Million US$)
    Table Europe Key Players Immunotherapy Drugs Market Share (2017-2018)
    Table Europe Immunotherapy Drugs Market Size by Type (2013-2018) (Million US$)
    Table Europe Immunotherapy Drugs Market Share by Type (2013-2018)
    Table Europe Immunotherapy Drugs Market Size by Application (2013-2018) (Million US$)
    Table Europe Immunotherapy Drugs Market Share by Application (2013-2018)
    Figure China Immunotherapy Drugs Market Size 2013-2018 (Million US$)
    Table China Key Players Immunotherapy Drugs Revenue (2017-2018) (Million US$)
    Table China Key Players Immunotherapy Drugs Market Share (2017-2018)
    Table China Immunotherapy Drugs Market Size by Type (2013-2018) (Million US$)
    Table China Immunotherapy Drugs Market Share by Type (2013-2018)
    Table China Immunotherapy Drugs Market Size by Application (2013-2018) (Million US$)
    Table China Immunotherapy Drugs Market Share by Application (2013-2018)
    Figure Japan Immunotherapy Drugs Market Size 2013-2018 (Million US$)
    Table Japan Key Players Immunotherapy Drugs Revenue (2017-2018) (Million US$)
    Table Japan Key Players Immunotherapy Drugs Market Share (2017-2018)
    Table Japan Immunotherapy Drugs Market Size by Type (2013-2018) (Million US$)
    Table Japan Immunotherapy Drugs Market Share by Type (2013-2018)
    Table Japan Immunotherapy Drugs Market Size by Application (2013-2018) (Million US$)
    Table Japan Immunotherapy Drugs Market Share by Application (2013-2018)
    Figure Southeast Asia Immunotherapy Drugs Market Size 2013-2018 (Million US$)
    Table Southeast Asia Key Players Immunotherapy Drugs Revenue (2017-2018) (Million US$)
    Table Southeast Asia Key Players Immunotherapy Drugs Market Share (2017-2018)
    Table Southeast Asia Immunotherapy Drugs Market Size by Type (2013-2018) (Million US$)
    Table Southeast Asia Immunotherapy Drugs Market Share by Type (2013-2018)
    Table Southeast Asia Immunotherapy Drugs Market Size by Application (2013-2018) (Million US$)
    Table Southeast Asia Immunotherapy Drugs Market Share by Application (2013-2018)
    Figure India Immunotherapy Drugs Market Size 2013-2018 (Million US$)
    Table India Key Players Immunotherapy Drugs Revenue (2017-2018) (Million US$)
    Table India Key Players Immunotherapy Drugs Market Share (2017-2018)
    Table India Immunotherapy Drugs Market Size by Type (2013-2018) (Million US$)
    Table India Immunotherapy Drugs Market Share by Type (2013-2018)
    Table India Immunotherapy Drugs Market Size by Application (2013-2018) (Million US$)
    Table India Immunotherapy Drugs Market Share by Application (2013-2018)
    Figure Central & South America Immunotherapy Drugs Market Size 2013-2018 (Million US$)
    Table Central & South America Key Players Immunotherapy Drugs Revenue (2017-2018) (Million US$)
    Table Central & South America Key Players Immunotherapy Drugs Market Share (2017-2018)
    Table Central & South America Immunotherapy Drugs Market Size by Type (2013-2018) (Million US$)
    Table Central & South America Immunotherapy Drugs Market Share by Type (2013-2018)
    Table Central & South America Immunotherapy Drugs Market Size by Application (2013-2018) (Million US$)
    Table Central & South America Immunotherapy Drugs Market Share by Application (2013-2018)
    Table Roche Company Details
    Table Roche Revenue in Immunotherapy Drugs Business (2013-2018) (Million US$)
    Figure Roche Revenue Growth Rate in Immunotherapy Drugs Business (2013-2018)
    Table Roche Recent Development
    Table Merck Company Details
    Table Merck Revenue in Immunotherapy Drugs Business (2013-2018)(Million US$)
    Figure Merck Revenue Growth Rate in Immunotherapy Drugs Business (2013-2018)
    Table Merck Recent Development
    Table Novartis Company Details
    Table Novartis Revenue in Immunotherapy Drugs Business (2013-2018)(Million US$)
    Figure Novartis Revenue Growth Rate in Immunotherapy Drugs Business (2013-2018)
    Table Novartis Recent Development
    Table Johnson & Johnson Company Details
    Table Johnson & Johnson Revenue in Immunotherapy Drugs Business (2013-2018)(Million US$)
    Figure Johnson & Johnson Revenue Growth Rate in Immunotherapy Drugs Business (2013-2018)
    Table Johnson & Johnson Recent Development
    Table Glaxosmithkline Company Details
    Table Glaxosmithkline Revenue in Immunotherapy Drugs Business (2013-2018)(Million US$)
    Figure Glaxosmithkline Revenue Growth Rate in Immunotherapy Drugs Business (2013-2018)
    Table Glaxosmithkline Recent Development
    Table Amgen Company Details
    Table Amgen Revenue in Immunotherapy Drugs Business (2013-2018)(Million US$)
    Figure Amgen Revenue Growth Rate in Immunotherapy Drugs Business (2013-2018)
    Table Amgen Recent Development
    Table Abbvie Company Details
    Table Abbvie Revenue in Immunotherapy Drugs Business (2013-2018)(Million US$)
    Figure Abbvie Revenue Growth Rate in Immunotherapy Drugs Business (2013-2018)
    Table Abbvie Recent Development
    Table Astrazeneca Company Details
    Table Astrazeneca Revenue in Immunotherapy Drugs Business (2013-2018)(Million US$)
    Figure Astrazeneca Revenue Growth Rate in Immunotherapy Drugs Business (2013-2018)
    Table Astrazeneca Recent Development
    Table Bristol-Myers Squibb Company Details
    Table Bristol-Myers Squibb Revenue in Immunotherapy Drugs Business (2013-2018)(Million US$)
    Figure Bristol-Myers Squibb Revenue Growth Rate in Immunotherapy Drugs Business (2013-2018)
    Table Bristol-Myers Squibb Recent Development
    Table ELI Lilly Company Details
    Table ELI Lilly Revenue in Immunotherapy Drugs Business (2013-2018)(Million US$)
    Figure ELI Lilly Revenue Growth Rate in Immunotherapy Drugs Business (2013-2018)
    Table ELI Lilly Recent Development
    Table Global Immunotherapy Drugs Market Size by Regions (Million US$) 2018-2025
    Figure Global Immunotherapy Drugs Market Size Share by Regions (2018-2025)
    Figure Global Immunotherapy Drugs Market Size Share by Regions in 2025
    Figure United States Immunotherapy Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure Europe Immunotherapy Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure China Immunotherapy Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure Japan Immunotherapy Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure Southeast Asia Immunotherapy Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure India Immunotherapy Drugs Market Size Forecast (2018-2025)(Million USD)
    Figure Central & South America Immunotherapy Drugs Market Size Forecast (2018-2025)(Million USD)
    Table Global Immunotherapy Drugs Market Size by Product (2018-2025) (Million US$)
    Figure Global Immunotherapy Drugs Market Size by Product (2018-2025)
    Figure Global Immunotherapy Drugs Market Size by Product in 2025
    Table Global Immunotherapy Drugs Market Size by Application (2018-2025) (Million US$)
    Figure Global Immunotherapy Drugs Market Size by Application (2018-2025)
    Figure Global Immunotherapy Drugs Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources